Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

As of the close on Tuesday, December 2, 2025, Cintas Corporation (NASDAQ: CTAS) – the uniform rental and facility‑services giant – is trading like a high‑quality franchise that investors suddenly fell out of love with. The share price sits around $184 per share, giving Cintas a market value in the mid‑$70 billion range and leaving the stock down roughly 16–17% over the last 12 months, even though the business continues to post high‑single‑digit revenue growth and expanding margins. StockAnalysis+1 Yet while the stock has cooled, new filings show large asset managers using the weakness to accumulate shares, and Wall Street
3 December 2025
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Company (NYSE: MMM) has quietly turned into one of 2025’s comeback stories on Wall Street. After years of legal headaches and sluggish growth, the industrial conglomerate now sits near a four‑year high, closing at $171.56 on 2 December 2025, just shy of its 52‑week peak around $172.85. That price gives 3M a market capitalization of about $91 billion, a trailing P/E of 27.4 and a forward P/E near 20.3, with a dividend yield around 1.7% on an annual payout of $2.92 per share. StockAnalysis Yet beneath the smooth headline numbers, investor views on 3M are sharply divided. Some see
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

On December 2, 2025, Bristol-Myers Squibb (NYSE: BMY) found itself at the center of two very different storylines: a revived $6.7 billion Celgene lawsuit and strong hematology data at ASH 2025. Together with a hefty dividend and low valuation multiples, these cross-currents are shaping how investors see BMY stock heading into 2026. BMY Stock Snapshot on 2 December 2025 On a day when the S&P 500 rose 0.25% and the Dow gained 0.39%, BMY underperformed peers: Johnson & Johnson ticked up slightly, while Pfizer and Abbott fell less than Bristol-Myers. MarketWatch For investors watching Google News and Discover, the headline
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management, Inc. (New) (NYSE: APO) entered December with a busy news day and a clear growth narrative that is catching Wall Street’s attention. On December 2, 2025, Apollo’s stock closed at $132.08, up 0.53% on the session, with after-hours trading nudging the price to $132.80. StockAnalysis Behind that modest price move sits a dense cluster of headlines: a fresh Goldman Sachs conference appearance, a Bank of England private-credit stress test, a Morgan Stanley upgrade and 20%+ growth forecasts, a high‑profile movie-studio auction where Apollo is helping finance a mega‑bid, and new macro commentary from Apollo’s own chief economist.
3 December 2025
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

As of December 2, 2025, CVS Health Corporation (NYSE: CVS) finds itself in a classic “good news, bad headlines” moment: the stock has pulled back after a strong 2025 rally, the company agreed to a federal settlement over insulin-pen billing, and yet Wall Street’s forecasts still point to further upside. Below is a structured rundown of the latest price action, news, forecasts and analyses as of and since December 2, 2025. Share price on December 2, 2025: dip after a big year On Tuesday, December 2, 2025, CVS Health shares fell about 1.9%, closing at $77.62, even as the broader
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, has packed a lot of news into the turn of the month. On December 2, 2025, the company reported near-record trading volumes, secured U.S. regulatory approval for a new securities clearing house, and continued to deal with the reputational fallout from last week’s rare 10‑hour trading outage. At the same time, options traders and Wall Street analysts are re‑positioning around the stock. This article brings together all the major CME stock news, forecasts and analyses dated December 2, 2025 (and closely related developments) to give you a single, SEO‑friendly
3 December 2025
ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (NYSE: COP) heads into the final month of 2025 as one of the most hotly debated energy stocks on Wall Street. On Tuesday, December 2, 2025, COP closed at $89.29, down 1.07% on the day, even as the S&P 500 and Dow Jones notched modest gains. That leaves the stock about 17% below its 52‑week high of $107.67, reached on December 3 last year, and still in the lower half of its trading range between $79.88 and $108.74. MarketWatch+1 Yet analysts broadly agree the stock may be trading at a discount: consensus 12‑month price targets cluster around $113–$116, implying
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare, Inc. (NYSE:HCA) is ending 2025 on a powerful note. After a year of double‑digit earnings growth and upgraded guidance, HCA stock is trading just above $500 per share, close to its 52‑week high of $520 and implying a market capitalization around $117 billion. MarketBeat On November 25, the stock touched an all‑time high of $515.85, and as of December 2 it was still near $503, more than 38% above its July 2024 peak of $363.05 — a rally powered by strong results from the company’s 191‑hospital network and an aggressive capital program. Becker’s Hospital Review This article rounds
3 December 2025
Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

TORONTO / NEW YORK — As of the close on 2 December 2025, Brookfield Corporation (NYSE: BN, TSX: BN) remains one of the most closely watched global alternative asset managers, sitting at the intersection of infrastructure, energy transition, AI data centers and retirement savings. On Tuesday, Brookfield’s own investor site showed BN at about US$46.46 on the NYSE (up 0.17% on the day) and C$65.01 on the TSX (up 0.22%), leaving the group valued at well over US$100 billion in market capitalization. Brookfield Corporation+1 Below is a detailed look at what changed around December 2, 2025, including institutional buying, balance-sheet
Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Key takeaways This article is for information and education only and is not financial advice or a recommendation to buy or sell any security. 1. How Booking Holdings stock has traded since December 2, 2025 As of the close on December 2, 2025, Booking Holdings finished the session at about $5,135.07, up 4.97% from the prior close of $4,891.81. Intraday, the stock traded between roughly $4,903 and $5,176, on heavier‑than‑usual volume. Google+1 That rally leaves BKNG: A December 2 note from StockInvest upgraded BKNG to a “Buy candidate” after the strong session, citing: StockInvest However, the same model remains cautious
TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

The TJX Companies, Inc. (NYSE:TJX) – owner of TJ Maxx, Marshalls, HomeGoods, TK Maxx and other off‑price banners – is heading into the crucial holiday period trading just below record highs after a strong third quarter and a flurry of fresh analyst and fund‑flow updates. As of the close on December 2, 2025, TJX shares changed hands around $150, within a whisker of their 52‑week high of $154.66 and well above the 52‑week low of $112.10. The market values the company at roughly $167 billion, with the stock on about 33x trailing earnings, according to Benzinga and StockInvest data. Benzinga
BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock, Inc. (NYSE: BLK), the world’s largest asset manager, entered December 2025 at the center of several powerful themes: the AI infrastructure build‑out, a booming Bitcoin ETF franchise, shifting views on long‑term Treasuries, and intensifying ESG politics. On 2 December 2025, BLK shares closed at about $1,038.62, down a modest 0.13% on the day and roughly flat for the year, even as Wall Street price targets still point to double‑digit upside. Investing.com+1 Below is a detailed rundown of the latest price action, key news, forecasts, and analyses as of 2 December 2025. 1. How BlackRock (BLK) Traded on 2 December
Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce, Inc. (NYSE: CRM) heads into a pivotal earnings week with its share price hovering in the mid‑$230s and Wall Street laser‑focused on whether the company’s big bet on AI and “agentic” workflows can re‑ignite growth. As of the close on December 2, 2025, Salesforce stock traded around $234.71, up roughly 0.8% on the day, with after‑hours quotes inching closer to $235.69. StockAnalysis Below is a comprehensive look at the latest price action, fresh analyst forecasts, institutional moves, and AI‑driven strategy updates, based on coverage and filings published up to December 2, 2025. Salesforce (CRM) stock price today and recent
3 December 2025
Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton Corporation plc (NYSE: ETN), the Irish‑domiciled intelligent power management giant, sits at the center of some of the biggest themes in markets right now: AI data centers, grid bottlenecks, electrification, and infrastructure spending. Yet the stock has been drifting lower since midsummer, even as earnings, margins and backlog hit record levels. On Tuesday, December 2, 2025, Eaton shares closed at about $333, down roughly 1.9% on the day and trading more than 16% below their 52‑week high near $400, on above‑average volume. MarketWatch+1 Over the last year, the shares are down around 11%, lagging both the S&P 500 and
3 December 2025
Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

As of December 2, 2025, Block, Inc. — the fintech behind Square, Cash App and Afterpay — is trading sharply lower even after reporting record holiday-shopping volumes and reiterating an ambitious multi‑year growth plan. Here’s a detailed look at what is happening with Block stock today, what the latest news means, and how Wall Street’s Block stock forecast is shaping up. Block stock today: sharp sell‑off on heavy volume On Tuesday, December 2, 2025, Block (NYSE: XYZ) closed around $60.11, down about 6.6% on the day. The stock traded between $59.97 and $65.28, with volume of roughly 20.7 million shares,
3 December 2025
McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

Updated December 2, 2025 As December trading gets underway, McDonald’s Corporation (NYSE: MCD) remains one of the market’s core defensive, dividend-paying blue chips — but not a screaming bargain. Shares recently closed at $300.72, down about 0.9% on the day, leaving the company with a market value a little above $210–220 billion. Investing.com At this level, investors are weighing a fresh dividend increase, holiday promotions such as the new “Grinch Meal,” steady (but not explosive) earnings growth and expanding AI investments against headwinds from squeezed low‑income consumers and a valuation many analysts describe as “full.” Convenience+3PR Newswire+3Reuters+3 Key takeaways for
3 December 2025
Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery, Inc. – Series A Common Stock (NASDAQ: WBD) is back at the center of Wall Street’s attention. As of December 2, 2025, the stock is trading around $24.53, up roughly 2.7% on the day on very heavy volume, after fresh reports that Netflix has submitted a mostly cash bid in the second round of an ongoing auction for the company. Reuters+1 The move caps an extraordinary year in which Warner Bros. Discovery shares have more than doubled and are hovering near new 52‑week highs, fueled by a full-blown bidding war involving Netflix, Paramount Skydance and Comcast. Investing.com+2Reuters+2
KLA Corporation (KLAC) Stock Soars on AI Chip Boom as Wall Street Lifts Price Targets – Latest News & Forecasts for December 2, 2025

KLA Corporation (KLAC) Stock Soars on AI Chip Boom as Wall Street Lifts Price Targets – Latest News & Forecasts for December 2, 2025

Published: December 2, 2025 KLA Corporation’s stock continues to ride the artificial intelligence (AI) semiconductor wave, adding another strong session on December 2, 2025, as analysts lift price targets and new research highlights its central role in the AI infrastructure build‑out. Below is a roundup of all the key news, forecasts and analyses around KLA stock as of December 2, 2025, plus what it could mean for investors watching KLAC. KLA Stock Today: KLAC Near Record Highs On December 2, 2025, KLA Corporation (NASDAQ: KLAC) closed at $1,189.86, up about 2.8% on the day, with an intraday high of $1,197.78
Pure Storage (PSTG) Stock Soars, Then Stumbles: Q3 2026 Earnings, AI Growth Story and 2026 Forecast on December 2, 2025

Pure Storage (PSTG) Stock Soars, Then Stumbles: Q3 2026 Earnings, AI Growth Story and 2026 Forecast on December 2, 2025

Pure Storage, Inc. (NYSE: PSTG) just delivered one of the most closely watched earnings reports in the AI infrastructure space — and the market’s reaction on December 2, 2025 was a full-on roller coaster. The flash‑storage specialist reported double‑digit revenue growth, rising subscription metrics and higher guidance for fiscal 2026, but also weaker GAAP profitability, softer cash flow and an eye‑watering valuation, leaving traders sharply divided. PR Newswire+2Quiver Quantitative+2 Below is a deep dive into the latest news, forecasts and analysis as of December 2, 2025, aimed at readers following PSTG on Google News and Discover. Key Takeaways for PSTG
Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts All figures in USD. Data current as of the close on December 1, 2025 and latest analyst/market reports available on December 2, 2025. 1. Where Intuitive Surgical Stock Stands Today Intuitive Surgical, Inc. (NASDAQ: ISRG), the maker of the da Vinci and Ion robotic systems, is trading near the upper end of its 52‑week range after a powerful post‑earnings run in Q4 2025. Long‑term shareholders have done extremely well: one recent analysis calculated that $1,000 invested a decade ago would be worth roughly $10,000
3 December 2025
1 564 565 566 567 568 606

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop